Amylyx Slashes Workforce by 70% After Controversial ALS Drug Fails Confirmatory Trial
Amylyx, the biopharma company under fire for its high-priced and ultimately ineffective ALS drug Relyvrio, is laying off a staggering 70% of […]
Amylyx, the biopharma company under fire for its high-priced and ultimately ineffective ALS drug Relyvrio, is laying off a staggering 70% of […]
For months, Novartis has hinted at layoffs coming for some of its global staff. Now, the news has come down from HQ. Novartis is […]
Layoffstracker.com